791 related articles for article (PubMed ID: 28331095)
1. Divergent Requirement of Fc-Fcγ Receptor Interactions for
Wang S; Ren H; Jiang W; Chen H; Hu H; Chen Z; Zhou P
J Virol; 2017 Jun; 91(11):. PubMed ID: 28331095
[TBL] [Abstract][Full Text] [Related]
2. Unraveling of a neutralization mechanism by two human antibodies against conserved epitopes in the globular head of H5 hemagglutinin.
Qian M; Hu H; Zuo T; Wang G; Zhang L; Zhou P
J Virol; 2013 Mar; 87(6):3571-7. PubMed ID: 23269809
[TBL] [Abstract][Full Text] [Related]
3. Broadly neutralizing anti-influenza antibodies require Fc receptor engagement for in vivo protection.
DiLillo DJ; Palese P; Wilson PC; Ravetch JV
J Clin Invest; 2016 Feb; 126(2):605-10. PubMed ID: 26731473
[TBL] [Abstract][Full Text] [Related]
4. A human antibody recognizing a conserved epitope of H5 hemagglutinin broadly neutralizes highly pathogenic avian influenza H5N1 viruses.
Hu H; Voss J; Zhang G; Buchy P; Zuo T; Wang L; Wang F; Zhou F; Wang G; Tsai C; Calder L; Gamblin SJ; Zhang L; Deubel V; Zhou B; Skehel JJ; Zhou P
J Virol; 2012 Mar; 86(6):2978-89. PubMed ID: 22238297
[TBL] [Abstract][Full Text] [Related]
5. Potential Role of Nonneutralizing IgA Antibodies in Cross-Protective Immunity against Influenza A Viruses of Multiple Hemagglutinin Subtypes.
Okuya K; Yoshida R; Manzoor R; Saito S; Suzuki T; Sasaki M; Saito T; Kida Y; Mori-Kajihara A; Kondoh T; Sato M; Kajihara M; Miyamoto H; Ichii O; Higashi H; Takada A
J Virol; 2020 Jun; 94(12):. PubMed ID: 32269119
[TBL] [Abstract][Full Text] [Related]
6. A novel humanized antibody neutralizes H5N1 influenza virus via two different mechanisms.
Tan Y; Ng Q; Jia Q; Kwang J; He F
J Virol; 2015 Apr; 89(7):3712-22. PubMed ID: 25609802
[TBL] [Abstract][Full Text] [Related]
7. Epitope specificity plays a critical role in regulating antibody-dependent cell-mediated cytotoxicity against influenza A virus.
He W; Tan GS; Mullarkey CE; Lee AJ; Lam MM; Krammer F; Henry C; Wilson PC; Ashkar AA; Palese P; Miller MS
Proc Natl Acad Sci U S A; 2016 Oct; 113(42):11931-11936. PubMed ID: 27698132
[TBL] [Abstract][Full Text] [Related]
8. Broadly neutralizing hemagglutinin stalk-specific antibodies require FcγR interactions for protection against influenza virus in vivo.
DiLillo DJ; Tan GS; Palese P; Ravetch JV
Nat Med; 2014 Feb; 20(2):143-51. PubMed ID: 24412922
[TBL] [Abstract][Full Text] [Related]
9. Optimal activation of Fc-mediated effector functions by influenza virus hemagglutinin antibodies requires two points of contact.
Leon PE; He W; Mullarkey CE; Bailey MJ; Miller MS; Krammer F; Palese P; Tan GS
Proc Natl Acad Sci U S A; 2016 Oct; 113(40):E5944-E5951. PubMed ID: 27647907
[TBL] [Abstract][Full Text] [Related]
10. Monovalent H5 vaccine based on epitope-chimeric HA provides broad cross-clade protection against variant H5N1 viruses in mice.
He F; Prabakaran M; Rajesh Kumar S; Tan Y; Kwang J
Antiviral Res; 2014 May; 105():143-51. PubMed ID: 24637255
[TBL] [Abstract][Full Text] [Related]
11. Conformational Stability of the Hemagglutinin of H5N1 Influenza A Viruses Influences Susceptibility to Broadly Neutralizing Stem Antibodies.
Wang W; Song HS; Keller PW; Alvarado-Facundo E; Vassell R; Weiss CD
J Virol; 2018 Jun; 92(12):. PubMed ID: 29593038
[TBL] [Abstract][Full Text] [Related]
12. Broadly Neutralizing Hemagglutinin Stalk-Specific Antibodies Induce Potent Phagocytosis of Immune Complexes by Neutrophils in an Fc-Dependent Manner.
Mullarkey CE; Bailey MJ; Golubeva DA; Tan GS; Nachbagauer R; He W; Novakowski KE; Bowdish DM; Miller MS; Palese P
mBio; 2016 Oct; 7(5):. PubMed ID: 27703076
[TBL] [Abstract][Full Text] [Related]
13. Influenza Virus Hemagglutinin Stalk-Specific Antibodies in Human Serum are a Surrogate Marker for
Jacobsen H; Rajendran M; Choi A; Sjursen H; Brokstad KA; Cox RJ; Palese P; Krammer F; Nachbagauer R
mBio; 2017 Sep; 8(5):. PubMed ID: 28928215
[TBL] [Abstract][Full Text] [Related]
14. Hierarchical and Redundant Roles of Activating FcγRs in Protection against Influenza Disease by M2e-Specific IgG1 and IgG2a Antibodies.
Van den Hoecke S; Ehrhardt K; Kolpe A; El Bakkouri K; Deng L; Grootaert H; Schoonooghe S; Smet A; Bentahir M; Roose K; Schotsaert M; Schepens B; Callewaert N; Nimmerjahn F; Staeheli P; Hengel H; Saelens X
J Virol; 2017 Apr; 91(7):. PubMed ID: 28077656
[TBL] [Abstract][Full Text] [Related]
15. Cross-protection of newly emerging HPAI H5 viruses by neutralizing human monoclonal antibodies: A viable alternative to oseltamivir.
Ren H; Wang G; Wang S; Chen H; Chen Z; Hu H; Cheng G; Zhou P
MAbs; 2016; 8(6):1156-66. PubMed ID: 27167234
[TBL] [Abstract][Full Text] [Related]
16. Unmasking Stem-Specific Neutralizing Epitopes by Abolishing N-Linked Glycosylation Sites of Influenza Virus Hemagglutinin Proteins for Vaccine Design.
Liu WC; Jan JT; Huang YJ; Chen TH; Wu SC
J Virol; 2016 Oct; 90(19):8496-508. PubMed ID: 27440889
[TBL] [Abstract][Full Text] [Related]
17. An anti-H5N1 influenza virus FcDART antibody is a highly efficacious therapeutic agent and prophylactic against H5N1 influenza virus infection.
Zanin M; Keck ZY; Rainey GJ; Lam CY; Boon AC; Rubrum A; Darnell D; Wong SS; Griffin Y; Xia J; Webster RG; Webby R; Johnson S; Foung S
J Virol; 2015 Apr; 89(8):4549-61. PubMed ID: 25673719
[TBL] [Abstract][Full Text] [Related]
18.
Sutton TC; Lamirande EW; Bock KW; Moore IN; Koudstaal W; Rehman M; Weverling GJ; Goudsmit J; Subbarao K
J Virol; 2017 Dec; 91(24):. PubMed ID: 29046448
[TBL] [Abstract][Full Text] [Related]
19. Structural Basis for the Broad, Antibody-Mediated Neutralization of H5N1 Influenza Virus.
Lin Q; Li T; Chen Y; Lau SY; Wei M; Zhang Y; Zhang Z; Yao Q; Li J; Li Z; Wang D; Zheng Q; Yu H; Gu Y; Zhang J; Chen H; Li S; Xia N
J Virol; 2018 Sep; 92(17):. PubMed ID: 29925655
[TBL] [Abstract][Full Text] [Related]
20. An antibody against a novel and conserved epitope in the hemagglutinin 1 subunit neutralizes numerous H5N1 influenza viruses.
Oh HL; Akerström S; Shen S; Bereczky S; Karlberg H; Klingström J; Lal SK; Mirazimi A; Tan YJ
J Virol; 2010 Aug; 84(16):8275-86. PubMed ID: 20519402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
